The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of HLA presented tumor-exclusive peptides in an independent cohort of head and neck squamous cell carcinoma.
 
Simon Laban
Honoraria - Bristol Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Consulting or Advisory Role - Bristol Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Speakers' Bureau - Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - Peptides for antigen-specific immunotherapy of head and neck cancer or other cancers (EP2023/071063, patent pending)
 
Sarah Schröder
No Relationships to Disclose
 
Lena Mühlenbruch
Patents, Royalties, Other Intellectual Property - EP2023/071063, patent pending
 
Adrian von Witzleben
No Relationships to Disclose
 
Tsima Abou Kors
No Relationships to Disclose
 
Cornelia Brunner
No Relationships to Disclose
 
Yacine Maringer
Patents, Royalties, Other Intellectual Property - EP21214728.4
 
Annika Nelde
No Relationships to Disclose
 
Naomi Hönisch Gravel
No Relationships to Disclose
 
Jonas Scheid
No Relationships to Disclose
 
Marissa L Dubbelaar
No Relationships to Disclose
 
Thorben Gross
No Relationships to Disclose
 
Johann M. Kraus
No Relationships to Disclose
 
Hans A. Kestler
No Relationships to Disclose
 
Paul-Stefan Mauz
No Relationships to Disclose
 
Hubert Löwenheim
No Relationships to Disclose
 
Jens Greve
Honoraria - CSL Behring GmbH, Takeda Pharma, BioCryst Pharma , KalVista Pharmaceuticals
Consulting or Advisory Role - CSL Behring GmbH, Takeda Pharma, KalVista Pharmaceuticals
Speakers' Bureau - CSL Behring GmbH, Takeda Pharma, BioCryst Pharma
 
Thomas K Hoffmann
Consulting or Advisory Role - MSD, BMS, Merck (Inst)
Speakers' Bureau - MSD, BMS, Merck (Inst)
 
Hans-Georg Rammensee
Stock and Other Ownership Interests - Immatics, Curevac, Viferaxs
Consulting or Advisory Role - Immatics
Research Funding - Rhovac, Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Multiple Patents (Inst)
 
Juliane S. Walz
Stock and Other Ownership Interests - ViferaXS
Consulting or Advisory Role - SwarmOncology, OrganoidScience
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - nventor on a patent on the peptides mentioned in the abstract